Chickenpox Antibodies Reveal a Vulnerable Gap Among Shanghai Teenagers

Varicella-zoster virus, the agent responsible for chickenpox, has long been regarded as a routine childhood illness, yet it continues to impose a measurable burden on public health systems around the world. A new study conducted in Pudong New Area, one of Shanghai’s most populous districts, has now mapped the immunological landscape of this virus among healthy residents and paired it with three years of outbreak surveillance, revealing a striking immunological gap in a very specific age band. The research, published in BMC Infectious Diseases by a team from the Shanghai Pudong New Area Center for Disease Control and Prevention and Fudan University’s Pudong Institute of Preventive Medicine, analyzed more than one thousand serum specimens collected between 2023 and 2025 and cross-referenced the findings with nationally reported case data and institutional outbreak records. The central message is unambiguous: adolescents aged ten to fourteen years carry the lowest antibody positivity of any age group examined, and this gap aligns precisely with the schools where outbreaks cluster most frequently.

The serological component of the study rested on 1,003 serum specimens drawn from healthy residents of the district, a sample comprising 508 males and 495 females with a median age of 9.16 years. Each specimen was tested for varicella IgG antibodies, the immunological footprint left by either natural infection or vaccination, using an enzyme-linked immunosorbent assay, the standard laboratory platform for quantifying antibody responses. Across the entire sample, the overall antibody positive rate was 59.12 percent, with a geometric mean concentration of 90.61 mIU/mL. That figure means that roughly four in ten residents sampled showed no detectable evidence of protection against a virus that spreads with remarkable efficiency in closed settings. Geometric mean concentration, rather than a simple arithmetic average, was used because antibody titers tend to follow a log-normal distribution, making the geometric summary a more faithful representation of the central tendency of the population’s immune status.

When the investigators stratified the results by age, a clear and consequential pattern emerged. The highest antibody positive rates were observed among residents aged 40 to 49 years and those aged 50 and above, cohorts who grew up in an era before widespread varicella vaccination and who therefore acquired immunity primarily through natural infection, which typically produces durable, high-titer antibody responses. At the opposite end of the spectrum, the 10 to 14 year age group recorded the lowest positivity rate of any stratum. To quantify this disparity formally, the team employed multivariable logistic regression, a statistical technique that estimates the odds of seropositivity while adjusting for confounding variables such as sex, survey year, and household registration status. The result was dramatic: individuals in the 10 to 14 year group had significantly lower odds of seropositivity compared with those aged 50 and above, with an odds ratio of 0.012 and a 95 percent confidence interval of 0.002 to 0.096, a finding that reached the stringent threshold of P less than 0.001. In practical terms, members of this adolescent cohort were more than eighty times less likely to show antibody evidence of protection than the oldest residents.

The regression analysis also illuminated the role of factors beyond age. Significant disparities in antibody positivity were observed across different survey years and across household registration statuses, a variable of particular relevance in Chinese cities where the population includes long-term residents with local hukou registration as well as migrants whose registration lies elsewhere. Migrant populations often face differential access to vaccination services and health records, and the observed differences in seropositivity by registration status suggest that such structural factors leave detectable immunological signatures. By adjusting for these variables simultaneously, the researchers could isolate the adolescent vulnerability as an independent effect rather than an artifact of demographic composition, strengthening the case that the age-specific gap reflects genuine differences in vaccination coverage or waning immunity rather than sampling noise.

Serology alone, however, cannot capture the dynamics of transmission, so the investigators turned to the national surveillance system, which recorded 5,055 reported varicella cases in the district during the same 2023 to 2025 window. The temporal distribution of case onset was far from uniform. May accounted for 10.29 percent of cases, marking a spring peak, while the months from October through December collectively contributed 33.08 percent, an autumn and early winter concentration that coincides with the school calendar. This seasonality is consistent with the respiratory and contact-based transmission route of the virus: schools reopen in September, susceptible children are brought into close and sustained contact, and the virus exploits the renewed network of interactions. The concentration of cases in these windows provides epidemiologists with actionable timing for interventions, since vaccination campaigns and school-based health checks conducted ahead of the autumn term would encounter the population at the moment of greatest vulnerability.

Beyond individual cases, the surveillance system captured 51 varicella outbreaks during the study period, a total comprising 50 clusters and one event classified as a public health emergency, involving 436 cases in aggregate. The institutional distribution of these outbreaks tells a story that mirrors the serological data with almost uncomfortable precision. Middle schools accounted for 27 of the 51 outbreaks, or 52.94 percent, and universities contributed another 14, or 27.45 percent. Together, secondary and tertiary educational institutions hosted more than four fifths of all recorded outbreaks. The correspondence is not coincidental: the 10 to 14 year olds with the lowest antibody positivity are precisely the students enrolled in middle schools, and university campuses concentrate young adults whose childhood vaccination may have occurred with a single dose or whose immunity has waned over time. In densely populated classrooms and dormitories, where the basic reproduction number of varicella can reach very high values among susceptible populations, even a modest proportion of unprotected individuals can sustain explosive chains of transmission.

One of the most technically interesting components of the study concerned the clinical presentation of outbreak-related cases across different immunization groups. The researchers compared body temperature, the presence of vesicles, and the occurrence of rash among cases stratified by vaccination status, and the statistical contrasts were revealing. Body temperature differed significantly across immunization groups, with a chi-square statistic of 341.076 and P less than 0.001, and the presence of vesicles also differed significantly, with a chi-square of 11.094 and P equal to 0.011. Rash, by contrast, did not differ significantly between groups. This pattern is consistent with the well-documented phenomenon of modified disease in vaccinated individuals, who, when they do contract breakthrough varicella, tend to present with fewer vesicular lesions and milder febrile responses than unvaccinated cases. The persistence of rash across groups, however, suggests that the diagnostic hallmark of the disease remains recognizable even in partially immune populations, which has practical implications for clinical surveillance and case ascertainment in school settings.

The findings arrive at a moment when many countries are reconsidering their varicella immunization schedules. A single-dose program, which was the historical standard in much of the world including China, reduces incidence substantially but leaves a residual susceptible pool, and mathematical models have repeatedly shown that one-dose coverage can shift the burden of disease toward older age groups, where severity is greater. Two-dose schedules, now recommended in the United States and several other countries, achieve markedly higher seroconversion rates and have been associated with dramatic declines in both disease and outbreaks. The Pudong data provide a real-world illustration of what an incomplete immunity landscape looks like at the population level: a seropositivity rate below 60 percent overall, a nadir in early adolescence, and an outbreak profile dominated by the very institutions housing the most susceptible students. The authors conclude that targeted attention to the varicella immunization status of students aged 10 years and older is crucial for reducing the risk of clustered outbreaks, a recommendation that points toward school-entry boosters, verification of vaccination records at middle school enrollment, and rapid immunization responses when clusters are detected.

For public health authorities in Shanghai and beyond, the study offers both a warning and a template. The warning is that varicella is not a solved problem: it persists as a source of disability-adjusted life years among children and adolescents globally, and the virus’s extraordinary contagiousness means that gaps in herd immunity translate quickly into institutional outbreaks. The template is the integrated methodology itself, combining population serosurveillance with case reporting and outbreak investigation, which allows immunization programs to be steered by evidence rather than assumption. As the authors note, the study provides a scientific basis for the optimization of varicella prevention and control strategies, and the convergence of serological, epidemiological, and clinical lines of evidence in a single district-level analysis demonstrates how granular local data can inform national immunization policy. If the adolescent immunity gap identified in Pudong is replicated elsewhere, the case for extending and strengthening varicella vaccination among school-age children will become difficult to ignore.

Subject of Research: Varicella-zoster virus antibody seroprevalence and outbreak epidemiology in Pudong New Area, Shanghai, 2023–2025

Article Title: Epidemiological analysis of varicella antibody levels and varicella outbreak surveillance in Pudong New Area, 2023–2025

Article References: Bai, Y., Deng, P., Li, J., Wu, Y., Cheng, W., Yang, L., & Yang, T. (2026). Epidemiological analysis of varicella antibody levels and varicella outbreak surveillance in Pudong New Area, 2023–2025. BMC Infectious Diseases. https://doi.org/10.1186/s12879-026-14489-8

Image Credits: AI Generated

DOI: 10.1186/s12879-026-14489-8

Keywords: varicella-zoster virus, chickenpox, IgG antibodies, seroprevalence, epidemiology, outbreak surveillance, immunization, adolescents, middle schools, Shanghai, public health, vaccination